EF Hutton Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $18
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Raises Target Price to $10
Analysts Are Bullish on Top Healthcare Stocks: GeoVax Labs (GOVX), Rohto Pharmaceutical Co (RPHCF)
Geovax Labs Analyst Ratings
Geovax Labs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Geovax Labs, Maintains $8 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax Labs (GOVX), Akebia Therapeutics (AKBA) and Aveanna Healthcare Holdings (AVAH)
Strong Buy Rating for GeoVax Labs on Government Support and Promising Trial Prospects
Geovax Labs Analyst Ratings
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $6
Noble Financial Sticks to Their Buy Rating for GeoVax Labs (GOVX)
Geovax Labs Analyst Ratings
Geovax Labs Analyst Ratings
GeoVax Labs (GOVX) Gets a Buy From Noble Financial
Buy Rating Reaffirmed for GeoVax Labs on Promising COVID-19 Vaccine Progress and Strategic Partnerships
Geovax Labs Analyst Ratings
Geovax Labs Analyst Ratings
Noble Financial Reaffirms Their Buy Rating on GeoVax Labs (GOVX)
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE)
HC Wainwright & Co. Reiterates Buy on Geovax Labs, Maintains $8 Price Target
No Data
No Data